Skip to main content

Table 5 Significant covariates with respect to the survival and related log-rank test P-Values

From: Radiomics based analysis to predict local control and survival in hepatocellular carcinoma patients treated with volumetric modulated arc therapy

Covariate

p-Value

HR

95%CI

Total Dose

0.01

0.08

0.01–0.63

Localization of tumour

0.04

0.26

0.06–1.10

PV thrombosis

<0.001

3.51

2.01–6.13

AJCC Stage

0.001

1.42

1.10–3.01

BCLC Stage

<0.001

1.38

0.95–2.84

Child Class

0.04

1.63

1.02–2.61

AFP initial level

<0.001

0.39

0.25–0.63

Tumour volume

<0.001

0.25

0.16–0.40

Age

0.006

2.02

1.20–3.39

Entropy (Histogram)

0.02

1.70

1.09–2.67

Compacity

<0.001

0.22

0.14–0.36

Contrast

0.01

2.11

1.14–4.12

Entropy

0.04

1.61

1.03–2.88

Dissimilarity

0.01

2.17

1.14–4.12

HGRE

0.02

1.80

1.07–3.01

SRHGE

0.02

1.69

1.06–2.67

LRHGE

0.04

1.71

1.02–2.88

GLNU

<0.001

0.23

0.13–0.39

RLNU

<0.001

0.25

0.16–0.40

HGZE

0.02

1.83

1.09–3.07

SZHGE

0.01

1.80

1.12–2.87

GLNU

<0.001

0.25

0.15–0.39

  1. Continuous numerical covariates have been split into two categories for calculating statistical test